Navigation Links
New Insight Into Most Common Forebrain Malformation
Date:8/11/2008

St. Jude researchers identify a molecular mechanism underlying a genetic brain malformation called holoprosencephaly

MEMPHIS, Tenn., Aug. 11 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital scientists have identified one of the molecular mechanisms underlying the genetic brain malformation called holoprosencephaly (HPE). The findings not only yield insights into the most common developmental malformation of the anterior brain and face in newborns, but also help in understanding the intricate process by which the brain forms in the developing fetus.

Led by St. Jude geneticist Guillermo Oliver, Ph.D., the researchers published their findings in the August 11, 2008, issue of the journal Developmental Cell.

"These findings are important, because, while genes that cause HPE have been identified, the interactions among those that produce HPE are not only complex, but poorly understood," Oliver said. "This represents a first step in understanding the mechanism of that interaction."

HPE occurs in about one in every 250 fetuses, frequently causing miscarriage or stillbirth. HPE is present in varying degrees in one in every 16,000 newborns. The disorder is characterized by a failure of the developing brain to separate into right and left hemispheres. Besides brain abnormalities, HPE is characterized by facial malformations such as cleft lip and cleft palate. HPE has been traced to mutations in any of nine genes, although researchers believe the disorder is also influenced by environmental factors such as maternal diabetes, infections during pregnancy or drugs.

In their studies, the researchers sought to understand the role in HPE of a gene that codes for a protein called Six3. In previous studies, Oliver and his colleagues had identified the Six3 protein as critical to fetal brain formation. Also, other studies had implicated defect-causing mutations in Six3 as involved in causing HPE, but they did not know the molecul
'/>"/>

SOURCE St. Jude Children's Research Hospital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. New insights into common knee injuries
3. SIV infection of natural hosts provides new insights into HIV disease complexity
4. Insight into the struggles of children with language impairments
5. Mothers Blood Could Offer Insights Into Fetal Health
6. Study Offers Insights Into Sensory Perceptions
7. Uncover Key Competitive Intelligence Insights in Webinars Hosted by Best Practices
8. Studies lend insights into colorectal cancer screening
9. Seven Finalists Announced for 2007 Insight Award for Customer Advocacy in Healthcare
10. Influenza: Insights into cell specificity of human vs. avian viruses
11. Genetic approach provides new insight into trastuzumab resistance in breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2014)... of Manchester have discovered why medication to treat asthma and ... Nature Medicine , show that drugs widely used to treat ... In the UK pneumonia, which is caused by an infection, ... more serious for babies, young children, the elderly, smokers and ... 5 million people in the UK are affected by asthma ...
(Date:7/27/2014)... Over the past five years, the ... thanks to many consumers valuing the taste and versatility ... Association of Canada's Canadian Coffee Drinking Study in 2011 ... per day. “This trend, coupled with many studies that ... tea on a daily basis, has stimulated consumer demand ...
(Date:7/27/2014)... The report, “Oil Filter & Fuel ... HCVs), Market Type (OE & Aftermarket), Filter Type (Oil ... - Industry Trends & Forecast to 2018”, defines and ... with analysis and forecasting of the global volume and ... to reach a revenue of $6.1 billion in 2018, ...
(Date:7/27/2014)... 1-Butene is a colorless, combustible gas with a ... be manufactured either through the separation from crude C4 ... alpha olefin (alkene) 1-Butene is a versatile chemical that ... chemicals such as linear light density polyethylene (LLDP), polybutene-1, ... market is extremely competitive. The market has several market ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 Metachromatic ... a lysosomal storage disease which is commonly listed ... among the sphingolipidoses as it affects the metabolism ... of myelin, the fatty covering which acts as ... and peripheral nervous systems. MLD involves cerebroside sulfate ...
Breaking Medicine News(10 mins):Health News:Drugs used to treat lung disease work with the body clock 2Health News:Coffee and Tea Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Coffee and Tea Production in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 2Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 3Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 4Health News:Oil Filter & Fuel Filter Market Worth $18.6 Billion by 2018 - Report by MarketsandMarkets 5Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America 1-Butene Market is Expected to Reach $794 million in 2018 - New Report by MicroMarket Monitor 4Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 2Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 3Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 4Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 5
... , MONDAY, Aug. 1 (HealthDay News) -- ... mental health disorders are at increased risk for chronic ... study. Researchers examined data from people in 10 ... Health Surveys initiative. The team looked at anxiety disorders ...
... mothers experienced psychological trauma during their pregnancies show signs ... The researchers discovered that this prenatal exposure to stress ... aging processes. The study results, which appear online this ... of Sciences , point to the importance of maternal ...
... (August 1, 2011) Two new studies published in ... Medicine (JNM) provide insight into the potential of ... dementia and to identify pharmaceuticals to slow the progress ... and the Alzheimer,s Association guidelines for detecting Alzheimer,s-related brain ...
... (HealthDay News) -- Despite the popularity of colon cleansing, ... done at home or in day spas -- offers any ... can cause serious side effects ranging from vomiting to kidney ... Colon cleansing -- also called colonic irrigation or colonic hydrotherapy ...
... leukemia chemotherapy drug may help breast cancer patients ... the widely-used drug, new research from the ... Interestingly, researchers found that taxoxifen combined with dasatinib, ... by cancer-associated fibroblasts in the surrounding tissue by ...
... July 31 (HealthDay News) -- A gene variant associated ... a team of researchers working together in a new ... gene variant was not present in European Americans and ... be identified in black Americans. The researchers, analysis ...
Cached Medicine News:Health News:Childhood Depression, Anxiety Tied to Pain in Adulthood 2Health News:UCI-led study links prenatal exposure to stress with accelerated cell aging 2Health News:New JNM research supports upcoming Alzheimer's disease guidelines 2Health News:Colon Cleansing Has No Health Benefit, May Harm: Report 2Health News:Leukemia drug reverses tamoxifen-resistance in breast cancer cells 2
(Date:7/24/2014)... PARK, Kan. , July 24, 2014 /PRNewswire/ ... of two compounds that will be added to ... with Australian-based CIMTECH Pty Ltd, a biotechnology company. ... PAR 122 have shown promise in bone regeneration ... license to develop the compounds for the veterinary ...
(Date:7/24/2014)... , Deutschland, und MARSEILLE ... -- , Weltweite ... ermöglicht QIAGEN die Entwicklung von Tests ... für Blutkrebs  Neuer Test weist ... mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf ...
(Date:7/24/2014)... Calif., July 24, 2014  Abaxis, Inc. (NasdaqGS: ... blood analysis systems, today reported financial results for the ... First quarter overview: , Revenues of $47.5 million, ... Diluted EPS of $0.21, up 50% over last year,s ... market revenues of $7.2 million, up 20% over last ...
Breaking Medicine Technology:Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... (NYSE: LMT ) has completed its acquisition of ... is the largest provider of outsourced medical evaluation services to ... 450,000 evaluations last year. Founded in 1981, ... to the Department of Defense, the VA and other U.S. ...
... BRUNSWICK, N.J., Sept. 27, 2011 Bluestar Silicones Senior ... to Control Bacterial Growth" at the upcoming Medical Silicones ... Dr. Hoy, the rising number of hospital acquired infections, ... are factors that contribute to growing demand for medical ...
Cached Medicine Technology:Bluestar Silicones to Present Antimicrobial Silicones at Medical Silicones Conference in Boston 2
The Vitek 2 - XL is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat ...
IDS Rapid ANA II System, a microbial identification system....
IDS Rapid STR, a microbial identification system....
IDS Rapid One, a microbial identification system....
Medicine Products: